Search Hanover.com
Display search count
|
|
|
|
|
|
|
|
|
|
|
|
Article 
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Article 
|
|
|
Article 
|
Safeguarding the research of life sciences organizations In the development of new medical treatments, drugs, and procedures, life sciences organizations may rely on research animals to meet the FDA approval requirements. When working with these organizations, agents should consider a carrier with deep expertise in life sciences, can provide the targeted coverage and risk management services these organizations need to successfully conduct their work safely. Article 
|
|
|
The growing use and emerging risks of exoskeleton technology As the adoption of exoskeleton technology increases, so do the associated risks for the companies that make it. For insurance agents, this represents a strategic opportunity, as organizations across technology and life sciences turn to agents to understand their evolving exposures and secure coverage tailored to their high-growth, innovative operations. Article 
|
